Results 31 to 40 of about 29,794,370 (246)

Targeting Indoleamine 2,3-Dioxygenase 1: Fighting Cancers via Dormancy Regulation

open access: yesFrontiers in Immunology, 2021
The connection between indoleamine 2,3-dioxygenase 1 (IDO1) and tumour dormancy – a quiescent state of tumour cells which has been consistently linked to metastasis and cancer recurrence – is rarely discussed despite the pivotal role of IDO1 in cancer ...
Chao Yang   +5 more
doaj   +1 more source

sj-docx-1-try-10.1177_11786469221138456 – Supplemental material for Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase

open access: yes, 2022
Supplemental material, sj-docx-1-try-10.1177_11786469221138456 for Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase by Saeko Yoshioka, Tomonori Ikeda, Sogo Fukuchi, Yurika Kawai,
Osamu Takikawa (230148)   +9 more
core   +1 more source

Dexamethasone Induces the Expression and Function of Tryptophan-2-3-Dioxygenase in SK-MEL-28 Melanoma Cells

open access: yesPharmaceuticals, 2021
Tryptophan-2,3-dioxygenase (TDO) is one of the key tryptophan-catabolizing enzymes with immunoregulatory properties in cancer. Contrary to expectation, clinical trials showed that inhibitors of the ubiquitously expressed enzyme, indoleamine-2,3 ...
Marta Cecchi   +4 more
doaj   +1 more source

Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: Expression, design optimization, uptake mechanism and nuclear localization [PDF]

open access: yes, 2009
Copyright © The Author 2009. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses?by-nc/2.0/uk/) which permits ...
Seow, WY, George, AJT, Yang, Y-Y
core   +1 more source

Tryptophan-degrading enzymes in tumoral immune resistance

open access: yesFrontiers in Immunology, 2016
Tryptophan is required for T lymphocyte effector functions. Its degradation is one of the mechanisms selected by tumors to resist immune destruction.
Nicolas van Baren   +5 more
doaj   +1 more source

Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors

open access: yesJournal of Medicinal Chemistry, 2021
The heme enzyme indoleamine 2,3-dioxygenase 1 (IDO1) plays an essential role in immunity, neuronal function, and aging through catalysis of the rate-limiting step in the kynurenine pathway of tryptophan metabolism. Many IDO1 inhibitors with different chemotypes have been developed, mainly targeted for use in anti-cancer immunotherapy. Lead optimization
Röhrig, Ute F   +11 more
openaire   +6 more sources

Inhibitory effects of a selective prostaglandin E2 receptor antagonist RQ-15986 on inflammation-related colon tumorigenesis in APC-mutant rats.

open access: yesPLoS ONE, 2021
Prostaglandin E2 receptor EP4 is involved in inflammation and related tumorigenesis in the colorectum. This study aimed to investigate the chemopreventive ability of RQ-15986, a selective EP4 antagonist, in colitis-related colorectal tumorigenesis.
Yohei Shirakami   +9 more
doaj   +1 more source

The role of placental tryptophan catabolism

open access: yesFrontiers in Immunology, 2014
This review discusses the mechanisms and consequences of degradation of tryptophan (Trp) in the placenta, focussing mainly on the role of indoleamine 2,3-dioxygenase-1 (IDO1), one of three enzymes catalyzing the first step of the kynurenine pathway of ...
Peter eSedlmayr   +2 more
doaj   +1 more source

Systemic tryptophan homeostasis

open access: yesFrontiers in Molecular Biosciences, 2022
Tryptophan is an essential amino acid, which is not only a building block for protein synthesis, but also a precursor for the biosynthesis of co-enzymes and neuromodulators, such as NAD/NADP(H), kynurenic acid, melatonin and serotonin.
Simon Klaessens   +9 more
doaj   +1 more source

N‑Benzyl/Aryl Substituted Tryptanthrin as Dual Inhibitors of Indoleamine 2,3-Dioxygenase and Tryptophan 2,3-Dioxygenase

open access: yes, 2019
Indoleamine 2,3-dioxygenase 1 (IDO1), which catalyzes the initial and rate-limiting step of the kynurenine pathway of tryptophan catabolism, has emerged as a key target in cancer immunotherapy because of its role in enabling cancers to evade the immune ...
Shengnan Zhang (1340988)   +10 more
core   +2 more sources

Home - About - Disclaimer - Privacy